RightFit
RecruitingPhase not listed

Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

Umbrella Long-Term Follow-Up Protocol

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
No age limits stated
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study collects follow-up information from patients who are in or have been in a Children's Oncology Group study. It aims to help doctors learn about the long-term effects of cancer treatment, reduce treatment-related problems, and improve patients' quality of life.

This clinical trial keeps track of and collects follow-up information from patients who are currently enrolled on or have participated in a Children's Oncology Group study. Developing a way to keep track of patients who have participated in Children's Oncology Group studies may allow doctors learn more about the long-term effects of cancer treatment and help them reduce problems related to treatment and improve patient quality of life.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Must live in the U.S. when joining this study.
  • The patient, parent, or legal guardian must sign a form agreeing to take part.
  • All rules for studies with people set by the study center, Food and Drug Administration (FDA), and National Cancer Institute (NCI) must be met.

Who can't join

    Simplified for readability. The official criteria below are what the study team uses.

    Official eligibility criteria

    Inclusion Criteria: * The patient must reside in the U.S. on the date of enrollment to ALTE05N1 * All patients and/or their parents or legal guardians must sign a written informed consent * All institutional, Food and Drug Administration (FDA), and National Cancer Institute (NCI) requirements for human studies must be met

    Study sites (163)

    AL

    AR

    AZ

    • Phoenix Childrens Hospital · Phoenix, AZ 85016Site Public Contact · Study contact · 602-546-0920Jessica Boklan · Principal investigatorMore trials in Phoenix
    • The University of Arizona Medical Center-University Campus · Tucson, AZ 85724Site Public Contact · Study contact · 520-626-9008Yi Zeng · Principal investigatorMore trials in Tucson

    CA

    CO

    CT

    DC

    DE

    FL

    GA

    HI

    IA

    ID

    IL

    IN

    KY

    LA

    MA

    • Floating Hospital for Children at Tufts Medical Center · Boston, MA 02111Site Public Contact · Study contact · 617-636-5535Michael J. Kelly · Principal investigatorMore trials in Boston

    MD

    MI

    MN

    MO

    MS

    • University of Mississippi Medical Center · Jackson, MS 39216Site Public Contact · Study contact · 601-815-6700Gail C. Megason · Principal investigatorMore trials in Jackson

    NC

    ND

    NH

    NJ

    NM

    NV

    NY

    OH

    OK

    OR

    PA

    RI

    SC

    SD

    TN

    TX

    UT

    VA

    VT

    WA

    WI

    WV

    • West Virginia University Charleston Division · Charleston, WV 25304Site Public Contact · Study contact · 304-388-9944Ashley E. Meyer · Principal investigatorMore trials in Charleston